🇺🇸 FDA
Patent

US 9783579

Compositions and methods for dengue virus chimeric constructs in vaccines

granted A61KA61K2039/5254A61K2039/70

Quick answer

US patent 9783579 (Compositions and methods for dengue virus chimeric constructs in vaccines) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5254, A61K2039/70, A61K31/7048, A61K31/713